Across TCGA pan-cancer cohorts, RPSAP7 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPSAP7 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher RPSAP7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPSAP7 expression acts as an unfavorable survival marker, although some lineages such as UVM and BRCA show a favorable association.
UVM, BRCA, and STAD are the cancer types where RPSAP7 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.